Education
About Us
Working with TipRanks
Follow Us
Clinica Baviera, SA (ES:CBAV)
BME:CBAV
CBAV Stock Chart & Stats
Day’s Range― - ―
52-Week Range€26.40 - €42.50
Previous CloseN/A
Volume285.00
Average Volume (3M)8.44K
Market Cap
€686.38M
Enterprise Value€596.00M
Total Cash (Recent Filing)€38.58M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)16.8
Beta0.29
Next Earnings
Feb 27, 2025EPS EstimateN/A
Next Dividend Ex-Date
Jun 11, 2025Dividend Yield3.07%
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,307,580
10 Day Avg. Volume11,316
30 Day Avg. Volume8,440
Financial Highlights & Ratios
PEG Ratio1.30
Price to Book (P/B)6.25
Price to Sales (P/S)0.00
P/FCF Ratio16.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Clinica Baviera News
PremiumCompany Announcements
Clínica Baviera Shareholders Approve Key Proposals at General Meeting
PremiumCompany Announcements
Clínica Baviera Appoints New Vice Presidents to BoardPremiumCompany Announcements
Clinica Baviera Proposes New Director Remuneration Policy for 2025-2028
PremiumCompany Announcements
Clínica Baviera Announces Ordinary General Meeting of Shareholders
PremiumCompany Announcements
Clinica Baviera Announces 2024 Dividend DetailsPremiumCompany Announcements
Clínica Baviera Share Sale Targets Qualified Investors
PremiumCompany Announcements
Clínica Baviera Share Sale Targeting Qualified Investors
PremiumCompany Announcements
Clinica Baviera Proposes 2024 Dividend DistributionOptions Prices
Currently, No data available
---
Ownership Overview
78.23% Insiders
―
Mutual Funds
― Other Institutional Investors
21.77% Public Companies and
Individual Investors
CBAV FAQ
What was Clinica Baviera, SA’s price range in the past 12 months?
Clinica Baviera, SA lowest stock price was €26.40 and its highest was €42.50 in the past 12 months.
What is Clinica Baviera, SA’s market cap?
Clinica Baviera, SA’s market cap is €686.38M.
When is Clinica Baviera, SA’s upcoming earnings report date?
Clinica Baviera, SA’s upcoming earnings report date is Feb 27, 2025 which is 103 days ago.
How were Clinica Baviera, SA’s earnings last quarter?
Clinica Baviera, SA released its earnings results on Nov 15, 2024. The company reported €0.249 earnings per share for the quarter, beating the consensus estimate of N/A by €0.249.
Is Clinica Baviera, SA overvalued?
According to Wall Street analysts Clinica Baviera, SA’s price is currently Overvalued.
Does Clinica Baviera, SA pay dividends?
Clinica Baviera, SA pays a Notavailable dividend of €1.271 which represents an annual dividend yield of 3.07%. See more information on Clinica Baviera, SA dividends here
What is Clinica Baviera, SA’s EPS estimate?
Clinica Baviera, SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clinica Baviera, SA have?
Clinica Baviera, SA has 16,307,580 shares outstanding.
What happened to Clinica Baviera, SA’s price movement after its last earnings report?
Clinica Baviera, SA reported an EPS of €0.249 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.601%.
Which hedge fund is a major shareholder of Clinica Baviera, SA?
Currently, no hedge funds are holding shares in ES:CBAV
Clinica Baviera Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Sold Shares
Worth €15.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
18.77%
Trailing 12-Months
Company Description
Clinica Baviera, SA
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Austria, and Italy. The company is based in Madrid, Spain.
Technical Analysis
Faes Farma
―
LABORATORIO REIG JOFRE
―
Naturhouse Health
―
PRIM, S.A.
―
Atrys Health SA
―